OC
HUM icon

Oppenheimer & Co’s Humana HUM Stock Holding History

Oppenheimer & Co’s Portfolio HUM Stock Details HUM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$687K Buy
3,965
+667
+20% +$137K 0.01% 1053
2025
Q4 		$845K Sell
3,298
-97
-3% -$25.4K 0.01% 871
2025
Q3 		$883K Buy
3,395
+130
+4% +$34.2K 0.01% 957
2025
Q2 		$798K Sell
3,265
-41
-1% -$10.2K 0.01% 957
2025
Q1 		$875K Sell
3,306
-7
-0.2% -$1.89K 0.01% 861
2024
Q4 		$841K Buy
3,313
+486
+17% +$130K 0.01% 866
2024
Q3 		$895K Hold
2,827
– – 0.01% 824
2024
Q2 		$1.06M Sell
2,827
-3,828
-58% -$1.29M 0.02% 751
2024
Q1 		$2.31M Buy
6,655
+2,844
+75% +$1.08M 0.04% 475
2023
Q4 		$1.74M Sell
3,811
-2,026
-35% -$999K 0.03% 536
2023
Q3 		$2.84M Buy
5,837
+394
+7% +$185K 0.06% 362
2023
Q2 		$2.43M Sell
5,443
-2,502
-31% -$1.26M 0.05% 420
2023
Q1 		$3.86M Buy
7,945
+935
+13% +$462K 0.08% 282
2022
Q4 		$3.59M Sell
7,010
-635
-8% -$334K 0.08% 290
2022
Q3 		$3.71M Sell
7,645
-4,975
-39% -$2.42M 0.09% 277
2022
Q2 		$5.91M Buy
12,620
+268
+2% +$119K 0.13% 186
2022
Q1 		$5.38M Sell
12,352
-584
-5% -$244K 0.1% 261
2021
Q4 		$6M Sell
12,936
-807
-6% -$357K 0.1% 224
2021
Q3 		$5.35M Sell
13,743
-884
-6% -$375K 0.1% 236
2021
Q2 		$6.47M Buy
14,627
+150
+1% +$65.5K 0.12% 205
2021
Q1 		$6.07M Buy
14,477
+1,754
+14% +$700K 0.12% 195
2020
Q4 		$5.22M Buy
12,723
+49
+0.4% +$20.4K 0.11% 212
2020
Q3 		$5.25M Sell
12,674
-2,145
-14% -$863K 0.13% 167
2020
Q2 		$5.75M Buy
14,819
+168
+1% +$62.9K 0.15% 142
2020
Q1 		$4.6M Sell
14,651
-1,127
-7% -$380K 0.14% 155
2019
Q4 		$5.78M Buy
15,778
+287
+2% +$91K 0.14% 164
2019
Q3 		$3.96M Sell
15,491
-105
-0.7% -$29.4K 0.11% 213
2019
Q2 		$4.14M Sell
15,596
-945
-6% -$240K 0.11% 206
2019
Q1 		$4.4M Sell
16,541
-719
-4% -$207K 0.12% 201
2018
Q4 		$4.95M Sell
17,260
-24
-0.1% -$7.61K 0.15% 145
2018
Q3 		$5.85M Buy
17,284
+937
+6% +$304K 0.15% 157
2018
Q2 		$4.87M Buy
16,347
+109
+0.7% +$31.9K 0.13% 173
2018
Q1 		$4.37M Sell
16,238
-3,100
-16% -$839K 0.11% 203
2017
Q4 		$4.8M Buy
19,338
+100
+0.5% +$24.7K 0.12% 196
2017
Q3 		$4.69M Buy
19,238
+163
+0.9% +$39.9K 0.13% 189
2017
Q2 		$4.59M Buy
19,075
+245
+1% +$55.5K 0.13% 194
2017
Q1 		$3.88M Buy
18,830
+203
+1% +$42K 0.11% 230
2016
Q4 		$3.8M Sell
18,627
-600
-3% -$114K 0.11% 217
2016
Q3 		$3.4M Sell
19,227
-807
-4% -$140K 0.1% 239
2016
Q2 		$3.6M Sell
20,034
-450
-2% -$79.9K 0.11% 224
2016
Q1 		$3.75M Buy
20,484
+100
+0.5% +$17.3K 0.11% 206
2015
Q4 		$3.64M Sell
20,384
-1,939
-9% -$340K 0.11% 217
2015
Q3 		$4M Sell
22,323
-952
-4% -$176K 0.12% 194
2015
Q2 		$4.45M Buy
23,275
+6,189
+36% +$1.15M 0.12% 192
2015
Q1 		$3.04M Sell
17,086
-1,424
-8% -$225K 0.08% 280
2014
Q4 		$2.66M Sell
18,510
-378
-2% -$51.6K 0.08% 313
2014
Q3 		$2.46M Sell
18,888
-517
-3% -$65.7K 0.07% 315
2014
Q2 		$2.48M Buy
19,405
+521
+3% +$61.7K 0.07% 315
2014
Q1 		$2.13M Buy
18,884
+13,562
+255% +$1.41M 0.06% 365
2013
Q4 		$550K Buy
5,322
+1,418
+36% +$139K 0.02% 780
2013
Q3 		$364K Sell
3,904
-1,136
-23% -$104K 0.01% 891
2013
Q2 		$425K Buy
+5,040
New +$398K 0.02% 780

Other funds holding HUM

Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Pzena Investment Management
Pzena Investment Management New York $30.8B AUM 11.29% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
SC
Sessa Capital New York $5.51B AUM 47.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Eagle Capital Management (New York)
Eagle Capital Management (New York) New York $29.8B AUM 12.13% 1-Year Est. Return

Oppenheimer & Co's HUM Position: Q1 2026 in Review

Oppenheimer & Co increased its Humana (HUM) stake by 20% in Q1 2026, buying an estimated $137K and bringing the position to 3,965 shares worth $687K. The position accounts for 0.01% of the portfolio, ranked #1053.

Oppenheimer & Co first reported a position in HUM in Q2 2013 and has held it in 52 quarters since. The position peaked at $6.47M in Q2 2021. 779 funds tracked by Wall St. Rank hold HUM as of Q1 2026.

  • Oppenheimer & Co held 3,965 shares of Humana worth $687K as of Q1 2026.
  • Oppenheimer & Co bought 667 Humana shares in Q1 2026, an estimated $137K.
  • Humana made up 0.01% of Oppenheimer & Co's portfolio in Q1 2026, its #1053 holding.
  • Oppenheimer & Co first reported a position in Humana in Q2 2013 and has held it in 52 quarters since.
  • Oppenheimer & Co's Humana position peaked at $6.47M in Q2 2021.
  • 779 funds tracked by Wall St. Rank held Humana as of Q1 2026.

Based on Oppenheimer & Co's 13F filing for Q1 2026, filed 24 Apr 2026.